Sarepta Therapeutics, Inc. (SRPT)
NGS · Common · CUSIP 002346104
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for SRPT and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
002346104
Market Cap
Large Cap
Previous Symbol
AVII (changed 7/12/2012)
Previous Name
AVI BioPharma, Inc.
Business: Sarepta Therapeutics programs and research focus span several therapeutic modalities, including RNA, gene therapy and gene editing. Sarepta is fueled by an audacious but important mission: to profoundly improve and extend the lives of patients with rare genetic-based diseases.

Company Contact

CEO
Douglas S. Ingram
CFO
Ian M. Estepan
Headquarters
215 First Street, Suite 415, Cambridge, MA 02142
Phone
617-274-4000 · Toll-Free 888-727-3782
Investor Relations
Ian Estepan · 617-274-4052 · iestepan@sarepta.com
General Email
investors@sarepta.com
Email Form
Material Request Form »
SEC EDGAR Filings
View filings »